Cognitive impairment in systemic lupus erythematosus

被引：0
作者：
Pizova, N. V. [1 ]
机构：
[1] Yaroslavl State Med Acad, Yaroslavl, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2013年 / 113卷 / 12期
关键词：
systemic lupus erythematosus; central nervous system; cognitive disorder; CENTRAL-NERVOUS-SYSTEM; NEUROPSYCHIATRIC MANIFESTATIONS; PSYCHIATRIC-DISORDER; PROTEIN ANTIBODIES; DYSFUNCTION; ASSOCIATION; PREVALENCE; DISEASE; AUTOANTIBODIES; INVOLVEMENT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：113 / 116
页数：4
相关论文
共 48 条
[1]   The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus [J].
Ainiala, H ;
Loukkola, J ;
Peltola, J ;
Korpela, M ;
Hietaharju, A .
NEUROLOGY, 2001, 57 (03) :496-500
[2]  
[Anonymous], 2006, J RHEUMATOL, V9, P66
[3]   RECURRENT STROKE AND MULTIINFARCT DEMENTIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH ANTIPHOSPHOLIPID ANTIBODIES [J].
ASHERSON, RA ;
MERCEY, D ;
PHILLIPS, G ;
SHEEHAN, N ;
GHARAVI, AE ;
HARRIS, EN ;
HUGHES, GRV .
ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (08) :605-611
[4]   Neuropsychiatric involvement in pediatric systemic lupus erythematosus [J].
Benseler, S. M. ;
Silverman, E. D. .
LUPUS, 2007, 16 (08) :564-571
[5]   Neuropsychiatric syndromes in lupus -: Prevalence using standarized definitions [J].
Brey, RL ;
Holliday, SI ;
Saklad, AR ;
Navarrete, MG ;
Hermosillo-Romo, D ;
Stallworth, CL ;
Valdez, CR ;
Escalante, A ;
del Rincón, I ;
Gronseth, G ;
Rhine, CB ;
Padilla, P ;
McGlasson, D .
NEUROLOGY, 2002, 58 (08) :1214-1220
[6]  
CARBOTTE RM, 1995, J RHEUMATOL, V22, P863
[7]   PREVALENCE OF COGNITIVE IMPAIRMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CARBOTTE, RM ;
DENBURG, SD ;
DENBURG, JA .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1986, 174 (06) :357-364
[8]   Cognitive impairment in systemic lupus erythematosus: a follow-up study [J].
Carlomagno, S ;
Migliaresi, S ;
Ambrosone, L ;
Sannino, M ;
Sanges, G ;
Di Iorio, G .
JOURNAL OF NEUROLOGY, 2000, 247 (04) :273-279
[9]  
Denburg S D, 1997, J Int Neuropsychol Soc, V3, P377
[10]   High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype [J].
Galasko, D ;
Chang, L ;
Motter, R ;
Clark, CM ;
Kaye, J ;
Knopman, D ;
Thomas, R ;
Kholodenko, D ;
Schenk, D ;
Lieberburg, I ;
Miller, B ;
Green, R ;
Basherad, R ;
Kertiles, L ;
Boss, MA ;
Seubert, P .
ARCHIVES OF NEUROLOGY, 1998, 55 (07) :937-945
12345